Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients
Achieving Improved Control of Blood Glucose Among Type 2 Diabetes Patients Through Continuous Glucose Monitoring & Care Coordinator Mediated Gains in Patient Self-Management Sophistication
1 other identifier
interventional
64
1 country
1
Brief Summary
The goal of the Twine / University of Michigan Diabetes Quality Improvement Initiative is to improve diabetes care quality using real time feedback with continuous glucose monitoring (CGM) and dietary coaching for lower carbohydrate consumption in a high-risk sub-cohort of outpatients with type 2 diabetes (T2D).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable type-2-diabetes-mellitus
Started Nov 2018
Typical duration for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2018
CompletedFirst Posted
Study publicly available on registry
October 15, 2018
CompletedStudy Start
First participant enrolled
November 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 20, 2021
CompletedFebruary 4, 2021
February 1, 2021
1.2 years
October 8, 2018
February 3, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Hemoglobin A1C
Hemoglobin A1C
1 year
Secondary Outcomes (6)
Weight Change
baseline to 1 year
Change in diabetes medication requirements
baseline to 1 year
Change in percentage of time glucose is out of range
baseline to 1 year
Blood Pressure
1 year
Change in rate of Micro-vascular complications
Baseline to 1 Year
- +1 more secondary outcomes
Study Arms (4)
Comparator- High Risk
ACTIVE COMPARATORA high risk sub group of those assigned to the comparator arm will be identified by their most recent A1C \> 8. Patients in this group will receive usual care from their Primary Care Physician and dietitian.
Comparator- Well Controlled
ACTIVE COMPARATORThe low risk sub group from the comparator arm (A1C \< 8) and those who are unlikely to benefit from an intensive behavioral intervention will get usual care by their Primary Care Physician and their dietitian.
Enhanced Care- High Risk
EXPERIMENTALA high risk sub group of those assigned to the enhanced care arm will be identified by their most recent A1C \> 8. Patients in this group will receive the intensive behavioral intervention which will incorporate lower carbohydrate diet, diet coaching, and more intensive glucose monitoring.
Enhanced Care- Well Controlled.
EXPERIMENTALThe low risk sub group from the enhanced care arm (A1C \< 8) and those who are unlikely to benefit from an intensive behavioral intervention will get usual care by their PCP and their dietitian. If they are found to be poorly controlled through monthly screening for risk, they may have the opportunity to move into the Enhanced Care High Risk group.
Interventions
Usual care from Primary Care Physician and dietitian.
The intensive behavioral intervention which will incorporate lower carbohydrate diet, diet coaching, and more intensive glucose monitoring.
Monthly screening of HbA1C to identify patents who have become poorly controlled in the interval.
Eligibility Criteria
You may qualify if:
- Michigan Medicine patient treated by a physician in the Family Medicine Department at the Chelsea Health Center
- Diagnosis of T2D as recorded in the patient's problem list or as documented by medication list and lab results
- HbA1C \>8 for the high-risk sub-cohort
You may not qualify if:
- Individuals for whom tight control (ie A1C \< 8) is not safe or recommended, including but not limited to older frail individuals at high-risk of hypoglycemia and falls or those with a life expectancy of less than 6 months due to a comorbid condition
- Individuals with cognitive or psychological diagnoses that might make CGM or low carbohydrate dieting risky, such as patients with eating disorders, uncontrolled psychotic - mental illness or those patients with dementia
- Women who are pregnant or breast feeding
- Individuals who had previous bariatric surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Michiganlead
- Twine Clinical Consultingcollaborator
Study Sites (1)
Chelsea Health Center
Chelsea, Michigan, 48118, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Caroline Richardson, M.D.
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 8, 2018
First Posted
October 15, 2018
Study Start
November 26, 2018
Primary Completion
February 7, 2020
Study Completion
January 20, 2021
Last Updated
February 4, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share